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Inflammatory cytokinesAbstract Lithium is an integral drug used in the management of acute mania, unipolar and bipolar
depression and prophylaxis of bipolar disorders. It has also been shown to reduce suicidal risk and
short term mortality. Few experimental studies have demonstrated the thyroid toxicity caused by
lithium as well as the possible protective effect of curcumin. Twenty four male albino rats were
divided into three groups; group I (control group), group II received lithium carbonate daily for
6 weeks and group III received the same dose of lithium carbonate as group II concomitantly with
curcumin for 6 weeks. The specimens were prepared for histopathological, immunohistochemical
and biochemical examination. Lithium-induced thyroid dysfunction evidenced by the histopatho-
logical and immunohistochemical changes represented by detached cells and vacuolated cytoplasm
of some follicular cells and highly significant increase in positive immunostained of thyroglobulin
and caspase-3 respectively. Moreover, a significant decrease in serum free triiodothyonine (FT3),
free thyroxine (FT4) concomitant with significantly increased thyroid stimulating hormone
(TSH) and pro-inflammatory cytokines, and thyroid lipid peroxidation (MDA) and nitric oxide
(NO) levels. Curcumin counteracted lithium-induced oxidative stress and inflammation as assessed
by restoration of the antioxidant defenses and diminishing of pro-inflammatory cytokines and
improvements in the degenerative changes of the thyroid gland. In conclusion, the present study
provides evidence that curcumin exerts thyroprotective effects against lithium carbonate mediated
by its antioxidant, anti-inflammatory and anti-apoptotic effect as indicated by caspase-3. This
report also confers that the use of this drug should be justified for long treatment under direct med-
ical supervision.
Crown Copyright  2016 Published by Elsevier B.V. on behalf of The Egyptian German Society for
Zoology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Lithium (Li), a psychomodulating drug, was noted to act as a
hematopoietic stimulant (Focosi et al., 2009). It is used as a
mood stabilizing drug. They have a potential role in the treat-
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conditions (Kalantari et al., 2015). It prevents mood swings
in patients with manic-depressive disorder (Bertram, 2001).
International multi-center studies yield strong evidence that
mortality and suicide rates could be lowered by long-term Li
treatment (Niethammer and Ford, 2007). It is a double edged
sword; it is a unique drug with an invaluable psychoactive
potential on one hand and a drug which can cause multisystem
toxicity and even death on the other hand (Kumarguru et al.,
2013).
The thyroid gland is the most important endocrine
gland for metabolic regulation (Cunningham, 2002).
Previous studies reported the thyroid disturbances and
dysfunction during lithium treatment, but it rarely-induced
parathyroid dysfunction (Nair et al., 2013). Li interference
with thyroid functions mainly at the level of hormonal
secretion and may result in goitrogenesis, hypothyroidism,
or rarely thyrotoxicosis (hyperthyroidism). The inhibitory
effect of Li on thyroid hormone secretion has been
used in treatment of thyrotoxicosis in selected situations.
Treatment with lithium is also accompanied rarely by
thyrotoxicosis, where it is not common and occurs mainly
after long-term use. The mechanism is unclear but is
believed to involve either autoimmune or destructive
thyroiditis. Transient euthyroid hyperthyroxinemia has been
previously reported after discontinuation of Li treatment
(George and Joshi, 2007).
El-bakary and Soliman (2009) reported that lithium
carbonate induced severe histological changes in the thyroid
gland of albino rat. In vitro, Li decreases the formation of
colloid droplets within thyroid follicular cells, a reflection
of decreased pinocytosis of colloid from the follicular
lumen (Williams et al., 1971). Within phagolysosomes, the
efficiency of proteolytic digestion of thyroglobulin may also
be impaired.
Curcumin (diferuloylmethane), a polyphenol compound, is
an active ingredient of tumeric (Curcuma longa). Importantly,
curcumin has chemopreventive properties and is a safe com-
pound for both humans and animals (Sharma et al., 2005).
Moreover, curcumin showed beneficial effects in many cancers
including colorectal cancer, breast cancer, skin cancer, and
oral cancer (Sa and Das, 2008). It is also used in Asian and
African traditional medicine to treat several mild or moderate
human diseases such as affections of the pulmonary and gas-
trointestinal systems; aches; wounds; sprains; and liver disor-
ders (Jurenka, 2009). In addition, a growing body of
evidence has unraveled the powerful antioxidant, anti-
inflammatory, anticancer and other activities of curcumin
depend on the ability of this compound to regulate a number
of cellular signal transduction pathways (Shanmugam et al.,
2011; Shehzad et al., 2011).
However, there have been few reports describing the
histopathological, immunohistochemical and biochemical
alterations of the thyroid gland treated by lithium carbonate
as well as the protective effect of curcumin and since Li is
still a fundamental and widely used drug in psychiatry and
Internal Medicine. The present study aims to investigate
the effect of lithium carbonate on the thyroid gland of
albino rat and the possible protective effect of curcumin
through histopathological, immunohistochemical and
biochemical studies.Materials and methods
Drugs and chemicals
Lithium carbonate (Prianil CR)
Lithium was obtained from the Nile Company for Pharmaceu-
ticals and Chemical industries (Cairo, Egypt). It is available in
the form of tablets, each one containing 400 mg of lithium car-
bonate. Curcumin was obtained from Merk Company
(Germany).
Animals and experimental design
Twenty four male adult albino rats (Rattus norvegicus), weigh-
ing about 140–180 g, were used in the current study. All the
animals were maintained under standard laboratory condi-
tions of temperature (25 C) and 12 h light and 12 h dark
cycles throughout the experimental period. They were housed
in standard cages and had free access to water ad libitum and
standard diet at the research center in Beni-Suef University.
Experiments were conducted as per the guidelines of Institu-
tional Animal Ethical Committee, Beni-Suef University. The
animals were divided into three groups (8 each) as follows:
Group I (negative control group)
Included 8 rats being kept without any treatment.
Group II
Included 8 rats, each received lithium carbonate (Prianil CR)
at a daily dose of 14.4 mg/kg b.wt/day according to El-
bakary and Soliman (2009) for 6 weeks. The drug was dis-
solved in distilled water then the calculated dose was given
orally using gastric intubation.
Group III
Included 8 rats, each received the dose of Li carbonate as
group II for the same period and concomitantly with curcumin
(60 mg/kg b. wt/day dissolved in distilled water; Sharma et al.,
2006) orally by gastric intubation.
Body weight gain was calculated from the difference
between the initial weight at the beginning and the final weight
at the end of the experiment. To reduce the error originating
from feeding, all experimental animals were fasted (water
was not restricted) for 10 h before recoding weight.
Samples collection and preparation
At the end of the six weeks of treatment, rats of different
groups were killed under light diethyl ether anesthesia. Blood
samples, collected from each rat, were allowed to coagulate
at room temperature and centrifuged at 1000g for 15 min
to separate serum. The sera were quickly removed and kept
at 20 C as aliquots for subsequent biochemical assays.
Immediately after sacrifice, thyroid glands from each rat were
quickly excised and divided into three portions. One portion
was homogenized (10% w/v in cold phosphate buffered saline
[PBS]) using a Teflon homogenizer (Glas-Col, Terre Haute,
IN, USA). The homogenate was centrifuged at 1000 g
for 10 min at 4 C and the clear supernatant was stored at
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isolation. The 3rd one was used for light microscopic,
histochemical and immunohistochemical studies.
Biochemical assays
Assay of serum hormonal levels
Serum free triiodothyronine (FT3), free thyroxine (FT4) and
thyrotropin (TSH) were estimated in Diabetic Endocrine
Metabolic Pediatric Unit, Center for Social and Preventive
Medicine, New Children Hospital, Faculty of Medicine, Cairo
University. The procedures used in these determinations were
applied according to the methods of Smals et al. (1981),
Larsen (1982) and Mandel et al. (1993) using reagent kits pur-
chased from Calbiotech INC (CBI), USA.
Assay of serum cytokines
The levels of proinflammatory cytokines (TNF-a & IL-6) in
serum of all tested groups were determined by specific ELISA
kits according to the manufacturer’s instructions (R&D Sys-
tems, USA). The concentration of proinflammatory cytokines
was determined spectrophotometrically at 450 nm. Standard
plots were constructed by using standard cytokines and the
concentrations for unknown samples were calculated from
the standard plot.
Assay of oxidative stress and antioxidant defense system
Lipid peroxidation content was assayed in thyroid gland
homogenates by measurement of malondialdehyde (MDA)
formation according to the method of Preuss et al. (1998).
Nitric oxide (NO) was determined according to the method
of Montgomery and Dymock (1961) using reagent kit pur-
chased from Biodiagnostics (Egypt). Reduced glutathione
(GSH) content was estimated according to Beutler et al.
(1963). Superoxide dismutase (SOD) activity was determined
following the method Marklund and Marklund (1974). Activ-
ities of catalase (CAT) and glutathione peroxidase (GPx) were
determined according to the methods of Cohen et al. (1970)
and Matkovics et al. (1998) respectively.
RNA isolation and quantitative reverse transcription-polymerase
chain reaction (qRT-PCR)
Gene expression analysis of TNF-a and IL-6 in the thyroid
gland was performed. Total RNA was isolated from frozen
samples using TRIzol reagent (Invitrogen) and treated with
RNAse-free DNAse (Invitrogen). Purified RNA was quanti-
fied and at 260 nm and RNA samples with A260/A280
ratiosP 1.7 were selected for reverse transcription.Table 1 Primer pairs used for qPCR.
Gene GenBank accession number
IL-6 NM_017019
TNF-a NM_012675
b-Actin NM_007393Additionally, RNA integrity was assured by formaldehyde-
containing agarose gel electrophoresis. Reverse transcription
was performed with 5 lg RNA using RevertAidTM First
Strand cDNA Synthesis Kit (Fermentas). cDNA was amplified
using SYBR Green master mix (Fermentas) in a total volume
of 25 ll using the primer set listed in Table 1. The PCR
reaction included initial denaturation at 95 C for 3 min, 40
cycles of denaturation at 95 C for 15 s, annealing at 55 C
for 30 s and extension at 72 C for 30 s, and a final step at
60 C increased about 0.5 C every 10 s up to 95 C. Melting
curve analysis was performed to check the specificity of the
used primers. Each experiment included a distilled water
control. The amplification data were analyzed following
the 2DDCt method (Livak and Schmittgen, 2001) and the
values were normalized to b-actin.
Light microscopic and histochemical study
For the histological preparations, thyroid gland tissues were
cut into small pieces and then fixed in 10% neutral buffered
formalin for 24 h. The tissue was routinely processed and sec-
tioned at 4–5 lm thickness with a microtome then stained with
H&E (Bancroft and Gamble, 2002) for histological studies,
while other sections were stained with periodic acid Schiff
(PAS) reaction for the demonstration of polysaccharides
(Hotchkiss, 1948; Kiernan, 1999).
Immunohistochemical study
Paraffin sections at 5 lm were incubated with either a mono-
clonal anti-rat caspase-3 antibody (Lab vision, USA) in a dilu-
tion of 1:500 (Nomura et al., 2009) for detection of apoptosis
or with a monoclonal anti human thyroglobulin (Dako, Japan)
(which has a cross reactivity with thyroglobulin from mouse
and rat) in a dilution of 1:100 according to Woo et al. (2009)
for demonstration of colloid using the avidin biotin peroxidase
method (Hsu et al., 1981).
Statistical analysis
Statistical analysis was performed using Statistical Package for
the Social Sciences (SPSS) version 20 for Windows software
system (SPSS Inc, Chicago, IL). Results were articulated as
mean ± standard error (SE) and all statistical comparisons
were made by means of a one-way ANOVA test. A P value
<0.05 was considered significant. When the difference
between groups was significant, post hoc analysis was carried
out by applying the LSD.Sequence 50–30
F: 50 TCC AAA CTG GAT ATA ACC AGG AAA T 30
R: 50 TTG TCT TTC TTG TTA TCT TGT AAG TTG TTC TT 30
F: 50 GAC CCT CAC ACT CAG ATC ATC TTC T 30
R: 50 TTG TCT TTG AGA TCC ATG CCA TT 30
F: 50TCACTATCGGCAATGTGCGG-30
R: 50 GCTCAGGAGGAGCAATGATG-30
Figure 1 Serum levels of FT3, FT4 and TSH in control, lithium
and lithium co-treated with curcumin. Data are M± SE (N= 6).
Values were considered significantly different at **P< 0.01,
***P< 0.001 versus control and ###P< 0.001 versus lithium-
treated group. FT3 free triiodothyronine, FT4 thyroxine, TSH
thyroid stimulating hormone, SE standard error.
Figure 2 Body weight changes (g) of control, lithium and lithium
co-treated with curcumin. Data are M± SE (N= 6). Values were
considered significantly different at ***P< 0.001 versus control
and ###P< 0.001 versus lithium-treated group. g gram, SE
standard error.
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Curcumin prevents weight gain in lithium-administered rats
Oral gavage of lithium carbonate for 6 weeks significantly
(P< 0.001) increased body weight. Simultaneous administra-
tion of curcumin alongwith lithiumpotentially ameliorates body
weight gain as compared to lithium administered group (Fig. 1).
Curcumin improves serum hormonal levels of lithium-
administered rats
The effect of curcumin on serum FT3, FT4 and TSH levels are
represented in Fig. 2. Lithium-administered rats showed asignificant (P< 0.001 and P< 0.01) decrease in serum FT3
and FT4, respectively as compared to control group.
Concurrent administration of curcumin along with lithium
significantly (P< 0.001) increased FT3 level as compared to
lithium treated group. TSH exhibited a different behavioral
pattern where its level was significantly (P< 0.001) increased
in the lithium treated group and significantly (P< 0.001)
decreased in group co-treated with both lithium and curcumin
as compared to the corresponding control groups.
Curcumin attenuates lithium-induced oxidative stress in the
thyroid gland of lithium-administered rats
Lithium administration produced a significant (P< 0.001)
increase in thyroid levels of the lipid peroxidation marker
MDA and NO when compared to the corresponding control
rats as depicted in Fig. 3a and b, respectively. Supplementation
of lithium-administered rats with curcumin significantly
(P< 0.001) ameliorated the altered levels of MDA and NO
when compared with the lithium supplemented group.
Conversely, GSH exhibited depleted (P< 0.001) content in
the thyroid tissues of the lithium administered group as com-
pared to the normal group. Curcumin co-administration sig-
nificantly (P< 0.05) increased thyroid GSH content when
compared to the Li treated group (Fig. 3c).
Similarly, activity of the antioxidant enzymes SOD, CAT
and GPx showed a significant (P< 0.001) decrease in thyroid
of the lithium-administered rats when compared with the con-
trol group (Fig. 3d–f). Oral supplementation of curcumin sig-
nificantly alleviated the activity of SOD (P< 0.01), CAT
(P< 0.05), and GPx (P< 0.001) as compared with Li treated
group of rats.
Curcumin reduces inflammation in lithium-administered rats
Considering the mean serum levels of TNF-a and IL-6, lithium
administration exhibited a significant (P< 0.001) elevation of
both pro-inflammatory cytokines when compared to those of
Figure 3 Thyroid oxidative stress and antioxidant defense system parameters in control, lithium and lithium co-treated with curcumin.
Data are M± SE (N= 6). Values were considered significantly different at ***P< 0.001 versus control and #P< 0.05, and ###P< 0.001
versus lithium-treated group. MDA malondialdehyde, NO nitric oxide, GSH reduced glutathione, SOD superoxide dismutase, CAT
catalase, GPx glutathione peroxidase, SE standard error.
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(P< 0.001) decreased both tested parameters when compared
to the Li treated group (Fig. 4a and b). Gene expression anal-
ysis showed significant (P< 0.001) up-regulation of thyroid
TNF-a and IL-6 in lithium administered rats when compared
with the corresponding controls (Fig. 4c and d). Concurrent
administration of curcumin along with lithium produced sig-
nificant (P< 0.001) down-regulation of the pro-
inflammatory cytokines mRNA.
Histopathology of the thyroid gland
Thyroid sections of control rats showed various sizes of thy-
roid follicles which were mainly lined by cubical follicular cells
with rounded vesicular nuclei. They contained on their centersacidophilic homogenous colloid. Between follicles, there were
interfollicular cells which are a part of parathyroid gland were
also observed (Figs. 5a and b).
Fig. 5c of the thyroid gland of a lithium treated group
showed markedly distended thyroid follicles which are lined
mainly by flat cells with flat nuclei and few low cuboidal
cells with apparently rounded nuclei. Moreover, detached
follicular cells were observed in the colloid of the follicles.
Thyroid follicles of variable activity appeared distended, while
other follicles were involuted. These follicles have a minimal
amount of colloid. Some follicles have shedded epithelial
lining. The thyrocytes of most of the follicles have vacuolated
cytoplasm (Fig. 5d). Disorganized and damaged follicles
with a wide interfollicular space were also seen, where most
of follicles were destroyed and appeared with vacuolated
Figure 4 Serum TNF-a and IL-6 levels and thyroid TNF-a and IL-6 mRNA expression in control, lithium and lithium co-treated with
curcumin. Data are M± SE (N= 6). Values were considered significantly different at ***P< 0.001 versus control and ###P< 0.001
versus lithium-treated group. TNF-a tumor necrosis factor alpha, IL-6 interleukin six, SE standard error.
12 S.M. Abd El-Twab, M. Abdul-Hamidcytoplasm and no colloid was observed in most follicles
(Fig. 5e).
Administration of lithium carbonate concomitantly with
curcumin ameliorated follicles except few vacuolations in
epithelial lining cells (Fig. 5f).Histochemistry of the thyroid gland
In the control group follicular cells showed moderate PAS
reaction in basal lamina, while colloid showed a strong reac-
tion (Fig. 6a). On the other hand, basal lamina of follicular
cells of the lithium treated group showed a weak PAS reaction.
Colloid showed a weak PAS reaction in almost follicles and
moderate reaction in few (Fig. 6b and c). However, after treat-
ment with lithium carbonate concomitantly with curcumin a
marked increase of PAS reaction was observed in colloid; nev-
ertheless there are some small follicles that are empty of colloid
(Fig. 6d).Immunohistochemistry of the thyroid gland
Immunohistochemically, control rats showed a marked strong
thyroglobulin protein expression in the colloid (Fig. 7a and b)
while, in lithium treated group there was a weak or no thy-
roglobulin protein expression in the colloid (Fig. 7c and d).
On the other hand, after treatment with lithium concomitantlywith curcumin a marked increase of thyroglobulin protein
expression was observed as compared to the lithium group
(Fig. 7e).
Control group showed a weak nuclear caspase-3 protein
expression of follicular cells (Fig. 8a), while the lithium treated
group displayed a marked strong caspase-3 protein expression
in follicular cells nuclei (Fig. 8b and c). On the contrary, the
administration of curcumin to lithium-treated rats obviously
reduced the elevated caspase-3 protein expression in nuclei
more or less to normal level (Fig. 8d).
Discussion
Even though lithium is one of the first-line drugs for acute and
maintenance treatment of bipolar disorder, its use as a thera-
peutic agent may be limited due to organ toxicity associated
with Li therapy (Lyoo et al., 2010). It has been previously
reported that Li therapy alters the thyroid status by blocking
iodothyronine formation and inhibition of thyroid hormone
release, concomitant with a compensatory increase of the
TSH levels (Lazarus, 1998).
Concerning the present study, Li-treated group showed
hypothyroidism which was evidenced biochemically by signif-
icant decrease in serum triiodothyronine (T3) and thyroxine
(T4) levels and elevated thyroid stimulating hormone (TSH)
level, histopathologically by decreased amount of colloid,
histochemically by decreased PAS reaction in the colloid and
Figure 5 (a & b) Photomicrograph of a section in the thyroid gland of a control rat showing thyroid follicles (F) of various sizes lined
mainly with simple cuboidal cells (arrows) surrounding central lumen filled with homogenous acidophilic colloid (Co). Notice the
interfollicular tissue (IF) and a part of the parathyroid gland (Pa) can also be seen (H & E; Scale bar = 200, 50 lm respectively). (c, d & e)
A photomicrograph of a section of the thyroid gland of a lithium treated group showing (c): markedly distended thyroid follicles. They are
lined mainly by flat cells with flat nuclei (arrow) and few low cuboidal cells with apparently rounded nuclei. Notice the detached follicular
cells in the colloid of some follicles (arrow heads). Scale bar = 50 lm. (d): Showing thyroid follicles of variable activity as some follicles
are markedly distended (D) and other follicles appear involuted (I). These follicles have minimal amount of colloid. Some follicles have
shedded epithelial lining (arrow head). The thyrocytes of most of the follicles have vacuolated cytoplasm (arrow). Scale bar = 50 lm. (e):
showing disorganized and damaged follicles (curved arrow) with a wide interfollicular space. Most of follicles are destroyed with the
epithelial lining of vacuolated cytoplasm and most follicles with no colloid (H & E; Scale bar = 50 lm). (f): Photomicrograph of a section
in the thyroid gland of rat treated with lithium concomitantly with curcumin showing most thyroid follicles appeared similar to those of
the control, while few follicles appeared with vacuolar cytoplasm. (H & E; Scale bar = 50 lm).
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expression in the colloid.
The anti-thyroid actions of Li were first investigated in
detail when it was noted that patients with psychiatric disease
treated with Li carbonate developed hypothyroidism and goi-
ter. Animal and human studies subsequently revealed that Li
increases intrathyroidal iodine content, inhibits the couplingof iodotyrosine residues to form iodothyronines (T4) and T3
(Bagchi et al., 1978), and inhibits release of T4 and T3
(Spaulding et al., 1972).
Several mechanisms have been suggested to explain Li
effects on thyroid function (Lazarus, 1998; Frankenfeld
et al., 2002). Li, a monovalent cation, after being concentrated
in the thyroid gland (McDermott et al., 1986) alters iodine
Figure 6 Photomicrograph of a section in the thyroid gland of a control rat showing (a): strong PAS reaction in the colloid (Co) and a
moderate reaction in the basement membrane (arrows). (PAS; Scale bar = 50 lm). (b & c): thyroid gland of lithium treated rat showing
weak PAS reaction in the colloid of some follicles and absence PAS reaction in the other. Notice a weak reaction in the basement
membrane. (PAS; Scale bar = 200, 50 lm respectively). (d): thyroid gland of rat treated with lithium concomitantly with curcumin
showing amelioration of positive PAS reaction in the basement membrane (arrow) and colloid (Co); nevertheless there are some small
follicles that are empty of colloid secretion. (PAS; Scale bar = 50 lm).
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retention and competition for the iodide transport within the
gland (Lazarus, 1998), impairs coupling of iodotyrosines resi-
dues in the formation T4 and T3 (Bagchi et al., 1978) and
the subsequent release of these iodothyronines. Although the
precise mechanism for this process remains uncertain, it may
reduce the pinocytosis of colloid from the follicular lumen,
leading to inhibition of colloid droplet formation (Williams
et al., 1971) as indicated histopathologically in the current
study as well as the blockade of cellular events mediated by
cyclic adenosine monophosphate (cAMP), either by directly
inhibiting adenyl cyclase as a substitute for cationic enzymatic
co-factors (e.g. Na+ or K+), or through the blockade of
cAMP at any step in the cellular microenvironment (Singer
and Rotenberg, 1973). A weak expression of thyroglobulin,
the glycoprotein precursor of the iodinated T4 and T3 synthe-
sized by the follicular cells and stored in the lumen of the fol-
licles (Pilling et al., 2007), in the colloid of Li administered
group seen in the present study could be considered. More-
over, Li has been shown to inhibit type I 50 de-iodinase, which
is responsible for the peripheral conversion of T4 to T3
(Kibirige et al., 2013).Thyroid hormone secretion is regulated by hypothalamic
thyrotropin-releasing hormone (TRH); which stimulates the
synthesis and release of TSH; that in turn increases the synthe-
sis and release of T4 and T3 through a cAMP-mediated mech-
anism. Since Li is also concentrated in the pituitary gland and
hypothalamus (Pfeifer et al., 1976), there may be an effect on
the hypothalamic-pituitary axis (HPA). Li-treated patients
have been shown to demonstrate transient increases in both
basal TSH and TRH-stimulated TSH levels (Lazarus, 1998),
with the latter suggesting a direct effect on the HPA. More-
over, a compensatory increase in serum TSH level secondary
to decreased thyroid hormone secretion cannot be neglected.
The resulting hypersecretion of TSH indicates the onset of
hypothyroidism as reported previously in patients treated with
Li (Lazarus et al., 1981; Lazarus, 1998; Kliner et al., 1999).
Concurrent administration of curcumin along with Li poten-
tially ameliorates serum hormonal level and this agrees with
the histological findings and could be attributed to some recov-
ered colloid-filled follicles and a marked increase of thyroglob-
ulin protein expression as compared to the Li group. In
addition, a compensatory decrease in serum TSH level
secondary to improved thyroid hormone secretion could be
Figure 7 Photomicrograph of a section in the thyroid gland of a control rat showing (a & b): strong immunohistochemical thyroglobulin
protein expression in the colloid (arrows). (Thyroglobulin immunohistochemical staining; Scale bar = 200, 50 lm respectively). (c & d):
thyroid gland of lithium treated rat showing weak or no immunohistochemical thyroglobulin protein expression in the colloid of follicles.
(Thyroglobulin immunohistochemical staining; Scale bar = 50, 50 lm respectively). (e): thyroid gland of rat treated with lithium
concomitantly with curcumin showing a marked increase of thyroglobulin protein expression (arrow) as compared to lithium group
(Thyroglobulin immunohistochemical staining; Scale bar = 50 lm).
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cumin against thyroid dysfunction which was reported in pre-
vious studies. Deshpande et al. (2002) revealed that treatment
of rats with turmeric extract attenuated the impact of
methimazole-induced hypothyroidism with less suppressed
T4 and T3 levels. Nabavi et al. (2011) reported that pretreat-
ment of rats with curcumin and quercetin prior to fluoride
exposure effectively kept the serum thyroid hormone levels
near the normal range.Because of low basal metabolic rates, Li-induced hypothy-
roidism (Kliner et al., 1999) which is generally associated with
some weight gain (Mackowiak et al., 1999). There was an obvi-
ous increase in body weight of Li-administered rats in the pre-
sent study. The overall amelioration in the thyroid hormone
profile of lithium treated rats secondary to curcumin adminis-
tration reflects the observed improvement in body weight gain.
Yet the exact mechanisms by which Li causes its deleterious
effects have not been exactly determined. However, oxidative
Figure 8 Photomicrograph of a section in the thyroid gland of a control rat showing (a): weak immunohistochemical caspase-3 protein
expression in nucleus of follicular cells (arrow). (Caspase-3 immunohistochemical staining; Scale bar = 20 lm). (b & c): thyroid gland of a
lithium treated rat showing marked strong immunohistochemical of caspase-3 protein expression in nucleus of follicular cells (arrows).
(Caspase-3 immunohistochemical staining; Scale bar = 20, 20 lm respectively). (d): thyroid gland of rat treated with lithium
concomitantly with curcumin showing obvious reduction of caspase-3 protein expression in nuclei more or less to normal level (Caspase-3
immunohistochemical staining; Scale bar = 20 lm).
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mechanisms of toxic effects of Li (Oktem et al., 2005;
Ahmad et al., 2011; Nciri et al., 2012; Toplan et al., 2013).
Superoxide, hydroxyl radicals and hydrogen peroxide, the
main intermediate reduction products of oxygen metabolism,
are controlled by various cellular defense mechanisms consist-
ing of enzymatic (SOD, CAT and GPx) and non-enzymatic
(GSH) scavenger components (Packer, 1993; Sardesai, 1995).
The primary reactive oxygen species (ROS) produced in the
aerobic organisms is superoxide radical that is a highly reactive
cytotoxic agent. SOD stimulate the dismutation of the super-
oxide anion (O2
) to hydrogen peroxide (H2O2) and molecular
oxygen (O2) (Tagami et al., 1992). H2O2, in turn, is further
detoxified to molecular oxygen and H2O by CAT and/or
GPx (Piper et al., 1995). Moreover, GPx can reduce lipid per-
oxides and other organic hydroperoxides that are highly cyto-
toxic products. Therefore, SOD, CAT and GPx constitute the
principal components of the antioxidant defense system and
their insufficiency can cause oxidative stress. GSH plays an
important role in the protection of cells from oxidative damage
via reducing disulfide groups of proteins and other cellular
molecules, or by scavenging free radicals and active oxygen
species. The latter effect occurs mainly by detoxifying hydro-
gen peroxides and lipid hydroperoxides through reactions cat-
alyzed by GPx (McLennan et al., 1991).Li-induced oxidative stress is highlighted by significantly
increased MDA and NO levels concomitant with GSH deple-
tion and decreased SOD, CAT and GPx activities in thyroid
tissues. Such findings are in good agreement with those of sev-
eral authors. Tandon et al. (1997) reported a significant
decrease in the activity of hepatic SOD after Li treatment.
Oktem et al. (2005) showed decreased renal GPx activity in
Li-treated rats. Malhotra and Dhawan (2008) observed that
lithium (1.1 g/kg in diet) treatment for 2 months significantly
increased lipid peroxidation levels and decreased the levels of
GSH and SOD activities. Khairova et al. (2012) found
decreased SOD in healthy subjects undergoing Li treatment.
The increased levels of MDA, lipid peroxidation marker, sug-
gest a net increase in the levels of oxygen free radicals which
could be due to their increased production and/or diminished
destruction (Giugliano et al., 1996). The produced NO in Li
treated rats may react with superoxide anion (O2
) in the mito-
chondria to produce peroxynitrite (ONOO), both of which
are important mediators of cell dysfunction (Hierholzer
et al., 1998; McKim et al., 2003). The exact nature of the
observed decrease in SOD activity in the present work might
be explained by a direct response to the increased formation
of active oxygen species as superoxide and hydroxyl radicals
(Toborek et al., 1992), and an irreversible inactivation of
SOD by its product hydrogen peroxide. The selective decrease
Curcumin mitigates lithium-induced thyroid dysfunction by modulating antioxidant status 17of CAT activity seen in the present study suggests chronic
exposure to oxidative stress, more specifically peroxidative
stress, as a result of increased endogenous production of
hydrogen peroxide. Decrease of GPx activity may result either
from a diminution of the protein synthesis or, more probably,
from an excessive production of superoxide ions, since accu-
mulation of both superoxide ions and carbonyls groups was
reported to inhibit the enzyme activity (Richard et al., 1997).
In addition, a decline in GSH content could attribute to
decreased GPx activity, since GSH is a substrate and cofactor
for this enzyme. Therefore, low GSH content indicates low
GPx activity, which may produce increased oxidative stress
propensity. Depletion of thyroid GSH content may be due
to its increased utilization in order to combat Li-induced free
radicals. Lipid peroxidation causes glutathione to be exhausted
by the glutathione-related enzymes that detoxify peroxides. A
reduction of GSH level is an indicator of increased LPO
(Malhotra and Dhawan, 2008). In the current study, curcumin
co-administration significantly decreased thyroid MDA and
NO levels. These findings are underlined by the significantly
increased GSH content and antioxidant enzymes activities
which suggests an antioxidant effect of curcumin. Curcumin
significantly inhibits ROS generation both in vitro and in vivo
(Biswas et al., 2005). Antioxidant properties of curcumin might
be attributed to one or more of the following interactions:
scavenging or neutralizing free radicals by oxygen quenching
and making it least available for oxidative reaction and/or
inhibition of oxidative enzymes like cytochrome P450, inter-
acting with oxidative cascade and preventing its outcome
and chelating and disarming oxidative properties of metal ions
such as iron (Unnikrishnan and Rao, 1995). It was reported
that dietary curcumin inhibits the generation of superoxide
anion and hydroxyl radical through preventing the oxidation
of Fe2+ in Fenton’s reaction, which generates OH radicals
(Reddy and Lokesh, 1994). An increased activity of the antiox-
idant enzymes and improved GSH content, observed in the
present study, following curcumin co-administration impli-
cates an augmentation in antioxidant capacity and reduced
peroxidation in membrane lipids that might be due to the free
radical scavenging activity of curcumin.
In conjunction with impaired antioxidant defense system,
the levels of circulatory pro-inflammatory cytokines (TNF-a
and IL-6) was significantly elevated in Li-administered rats.
These elevated levels could be attributed to Li-induced upreg-
ulation of thyroid TNF-a and IL-6. TNF-a induces the expres-
sion of inducible nitric oxide synthase (iNOS) and stimulates
production of NO, contributing to nitrosative stress as
reported by Hierholzer et al. (1998). Curcumin co-
administration potentially down regulated the thyroid expres-
sion of TNF-a and IL-6, suggesting its important role in the
attenuation of Li-induced inflammatory cascade and reflecting
its anti-inflammatory potential (Brouet and Oshimima, 1995).
Regarding the present immunohistochemical study, apop-
tosis of follicular cells was observed in Li-treated group by a
strong caspase-3 protein expression. Caspase-3, a member of
interlukein converting enzymes, is the most common one
involved in the execution of apoptosis in various cell types
(Cohen, 1997). Thus, it is well suited as a read-out in an apop-
tosis assay and its increased expression reflects an increase in
apoptosis (Kurokawa and Kornbluth, 2009). Degeneration
and apoptosis of follicular cells have been previously reported
(Jeong et al., 2006; Yu et al., 2008). This might be owed tooxidative damage caused by Li with generation of ROS and
lipid peroxidation.
In the current study, co-administration of curcumin to ani-
mals treated with Li regained the structural changes of the thy-
roid gland nearly similar to normal. This is in agreement with
Nabavi et al. (2011) who reported that the polyphenolic com-
pounds of curcumin exert impressive protection against thy-
roid dysfunction in rats induced by fluoride in their drinking
water.
Curcumin has been reported to scavenge oxygen free radi-
cals and inhibits LP and protects cellular macromolecules,
including DNA from oxidative damage (Polasa et al., 2004).
It is known to be a multi-functional agent, such as powerful
antioxidant, anti-diabetic, anti-inflammatory and anti-cancer
agent (Biswas et al., 2005).
Conclusion
The toxic effect of lithium should be kept in mind especially
during chronic usage. Curcumin could ameliorate Li toxicity
and histopathology of the thyroid gland when it is adminis-
tered concomitant with Li which may be mediated by its
antioxidant, anti-inflammatory and anti-apoptotic potentials.
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